Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Montegaard J"'
Autor:
Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ryan CE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lampson BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ren Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Tyekucheva S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Kim AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Weinstock M; Department of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA., Montegaard J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Walker HA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Greenman C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Patterson V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lo S; Stamford Hospital, Stamford, CT., Olszewski AJ; Brown University Health, Providence, RI., Arnason JE; Department of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA., Ahn IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Dec 07, pp. JCO2402503. Date of Electronic Publication: 2024 Dec 07.
Autor:
Anderson MA; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC 3000, Australia.; Division of Blood Cells and Blood Cancers, The Walter and Eliza Hall Institute, Melbourne, VIC 3000, Australia.; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC 3000, Australia., Walewska R; University Hospitals Dorset, NHS Foundation Trust, Bournemouth BH7 7DW, UK., Hackett F; Cancer Services Directorate, University Hospital Limerick UL Hospitals Group, St. Nessan's Road, V94 F858 Limerick, Ireland., Kater AP; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., Montegaard J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., O'Brien S; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA 92868, USA., Seymour JF; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC 3000, Australia., Smith M; Department of Haematology, Chesterfield Royal Hospital NHS Foundation Trust, Chesterfield S44 5BL, UK., Stilgenbauer S; Division of CLL, Department of Internal Medicine III, Ulm University, 89081 Ulm, Germany., Whitechurch A; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC 3000, Australia., Brown JR; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Feb 28; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 28.
Autor:
Ahn IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Brander DM; Department of Medicine, Duke University Medical Center, Durham, NC., Ren Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Zhou Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Tyekucheva S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Walker HA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Black R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Montegaard J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Alencar A; Division of Hematology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Shune L; Department of Hematologic Malignancies, University of Kansas Cancer Center, Westwood, KS., Omaira M; Department of Medical Oncology, West Michigan Cancer Center, Kalamazoo, MI., Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Crombie J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Arnason J; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA., Hochberg EP; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA., Takvorian RW; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA., Abramson JS; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2024 Feb 27; Vol. 8 (4), pp. 832-841.
Autor:
Davids, M. S., Rogers, K. A., Jain, N., Tyekucheva, S., Ren, Y., Carey, C., Montegaard, J., Hajdenberg, M., Ryan, C. E., Merryman, R., Kim, A., Crombie, J., Jacobson, C. A., LaCasce, A. S., Fisher, D. C., Ahn, I. E., Parry, E. M., Brown, J. R., Thompson, P. A.
Publikováno v:
Hematological Oncology; Jun2023 Supplement S2, Vol. 41, p466-468, 3p
Autor:
Ahn, I. E., Brander, D. M., Ren, Y., Zhou, Y., Tyekucheva, S., Walker, H. A., Black, R., Montegaard, J., Alencar, A., Shune, L., Omaira, M., Jacobson, C. A., Armand, P., Ng, S., Crombie, J., Fisher, D. C., LaCasce, A. S., Arnason, J., Hochberg, E. P., Takvorian, R. W.
Publikováno v:
Hematological Oncology; Jun2023 Supplement S2, Vol. 41, p231-233, 3p
Autor:
Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Rogers KA; Division of Hematology, The Ohio State University, Columbus, OH., Tyekucheva S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Wang Z; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Pazienza S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Renner SK; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and., Montegaard J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ihuoma U; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lehmberg TZ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA., Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Thompson PA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood [Blood] 2022 Feb 03; Vol. 139 (5), pp. 686-689.
Autor:
Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: matthew_davids@dfci.harvard.edu., Lampson BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Tyekucheva S; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, MA, USA., Wang Z; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, MA, USA., Lowney JC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pazienza S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Montegaard J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Patterson V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Weinstock M; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ng SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kim AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Arnason JE; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Oct; Vol. 22 (10), pp. 1391-1402. Date of Electronic Publication: 2021 Sep 14.
Autor:
Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. matthew_davids@dfci.harvard.edu., Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Tyekucheva S; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA., McDonough M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hanna J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lee B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Francoeur K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Montegaard J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Odejide O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Arnason J; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Leukemia [Leukemia] 2021 Apr; Vol. 35 (4), pp. 1064-1072. Date of Electronic Publication: 2020 Aug 20.
Autor:
El-Serafi, Ibrahim1,2 (AUTHOR) i.elserafi@ajman.ac.ae, Steele, Sinclair3 (AUTHOR), Mudigonda, Koteshwara (AUTHOR)
Publikováno v:
Advances in Pharmacological & Pharmaceutical Sciences. 6/27/2024, Vol. 2024, p1-16. 16p.
Autor:
Negara, Ivan1,2 (AUTHOR) ivan.negara@icgeb.org, Tomuleasa, Ciprian3 (AUTHOR) ciprian.tomuleasa@gmail.com, Buruiana, Sanda2 (AUTHOR), Efremov, Dimitar G.1,4 (AUTHOR) ivan.negara@icgeb.org
Publikováno v:
Cancers. Jun2024, Vol. 16 Issue 12, p2170. 21p.